Global Nuclear Medicine & Radio Pharmaceuticals Market Research Report 2017

October 2017 | 102 pages | ID: GA14F103C0FEN
QYResearch

Abstracts

In this report, the global Nuclear Medicine & Radio Pharmaceuticals market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Nuclear Medicine & Radio Pharmaceuticals in these regions, from 2012 to 2022 (forecast), covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global Nuclear Medicine & Radio Pharmaceuticals market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

• GE Healthcare
• Philips Healthcare
• Siemens Healthcare
• Toshiba
• Hitachi
• Carestream
• Esaote
• Shimadzu
• TriFoil Imaging
• Biosensors International Group, Ltd

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
• Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

• Diagnostic Applications: SPECT, PET.
• Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Nuclear Medicine & Radio Pharmaceuticals Market Research Report 2017

1 NUCLEAR MEDICINE & RADIO PHARMACEUTICALS MARKET OVERVIEW

1.1 Product Overview and Scope of Nuclear Medicine & Radio Pharmaceuticals
1.2 Nuclear Medicine & Radio Pharmaceuticals Segment by Type (Product Category)
  1.2.1 Global Nuclear Medicine & Radio Pharmaceuticals Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
  1.2.2 Global Nuclear Medicine & Radio Pharmaceuticals Production Market Share by Type (Product Category) in 2016
  1.2.3 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
  1.2.4 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
1.3 Global Nuclear Medicine & Radio Pharmaceuticals Segment by Application
  1.3.1 Nuclear Medicine & Radio Pharmaceuticals Consumption (Sales) Comparison by Application (2012-2022)
  1.3.2 Diagnostic Applications: SPECT, PET.
  1.3.3 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.
1.4 Global Nuclear Medicine & Radio Pharmaceuticals Market by Region (2012-2022)
  1.4.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
  1.4.2 North America Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 China Status and Prospect (2012-2022)
  1.4.5 Japan Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Status and Prospect (2012-2022)
  1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Nuclear Medicine & Radio Pharmaceuticals (2012-2022)
  1.5.1 Global Nuclear Medicine & Radio Pharmaceuticals Revenue Status and Outlook (2012-2022)
  1.5.2 Global Nuclear Medicine & Radio Pharmaceuticals Capacity, Production Status and Outlook (2012-2022)

2 GLOBAL NUCLEAR MEDICINE & RADIO PHARMACEUTICALS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Nuclear Medicine & Radio Pharmaceuticals Capacity, Production and Share by Manufacturers (2012-2017)
  2.1.1 Global Nuclear Medicine & Radio Pharmaceuticals Capacity and Share by Manufacturers (2012-2017)
  2.1.2 Global Nuclear Medicine & Radio Pharmaceuticals Production and Share by Manufacturers (2012-2017)
2.2 Global Nuclear Medicine & Radio Pharmaceuticals Revenue and Share by Manufacturers (2012-2017)
2.3 Global Nuclear Medicine & Radio Pharmaceuticals Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Nuclear Medicine & Radio Pharmaceuticals Manufacturing Base Distribution, Sales Area and Product Type
2.5 Nuclear Medicine & Radio Pharmaceuticals Market Competitive Situation and Trends
  2.5.1 Nuclear Medicine & Radio Pharmaceuticals Market Concentration Rate
  2.5.2 Nuclear Medicine & Radio Pharmaceuticals Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL NUCLEAR MEDICINE & RADIO PHARMACEUTICALS CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Nuclear Medicine & Radio Pharmaceuticals Capacity and Market Share by Region (2012-2017)
3.2 Global Nuclear Medicine & Radio Pharmaceuticals Production and Market Share by Region (2012-2017)
3.3 Global Nuclear Medicine & Radio Pharmaceuticals Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Nuclear Medicine & Radio Pharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Nuclear Medicine & Radio Pharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Nuclear Medicine & Radio Pharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Nuclear Medicine & Radio Pharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Nuclear Medicine & Radio Pharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Nuclear Medicine & Radio Pharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL NUCLEAR MEDICINE & RADIO PHARMACEUTICALS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)

4.1 Global Nuclear Medicine & Radio Pharmaceuticals Consumption by Region (2012-2017)
4.2 North America Nuclear Medicine & Radio Pharmaceuticals Production, Consumption, Export, Import (2012-2017)
4.3 Europe Nuclear Medicine & Radio Pharmaceuticals Production, Consumption, Export, Import (2012-2017)
4.4 China Nuclear Medicine & Radio Pharmaceuticals Production, Consumption, Export, Import (2012-2017)
4.5 Japan Nuclear Medicine & Radio Pharmaceuticals Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Production, Consumption, Export, Import (2012-2017)
4.7 India Nuclear Medicine & Radio Pharmaceuticals Production, Consumption, Export, Import (2012-2017)

5 GLOBAL NUCLEAR MEDICINE & RADIO PHARMACEUTICALS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Nuclear Medicine & Radio Pharmaceuticals Production and Market Share by Type (2012-2017)
5.2 Global Nuclear Medicine & Radio Pharmaceuticals Revenue and Market Share by Type (2012-2017)
5.3 Global Nuclear Medicine & Radio Pharmaceuticals Price by Type (2012-2017)
5.4 Global Nuclear Medicine & Radio Pharmaceuticals Production Growth by Type (2012-2017)

6 GLOBAL NUCLEAR MEDICINE & RADIO PHARMACEUTICALS MARKET ANALYSIS BY APPLICATION

6.1 Global Nuclear Medicine & Radio Pharmaceuticals Consumption and Market Share by Application (2012-2017)
6.2 Global Nuclear Medicine & Radio Pharmaceuticals Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL NUCLEAR MEDICINE & RADIO PHARMACEUTICALS MANUFACTURERS PROFILES/ANALYSIS

7.1 GE Healthcare
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Main Business/Business Overview
7.2 Philips Healthcare
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Main Business/Business Overview
7.3 Siemens Healthcare
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Main Business/Business Overview
7.4 Toshiba
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Toshiba Nuclear Medicine & Radio Pharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Main Business/Business Overview
7.5 Hitachi
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Hitachi Nuclear Medicine & Radio Pharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Main Business/Business Overview
7.6 Carestream
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Carestream Nuclear Medicine & Radio Pharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Main Business/Business Overview
7.7 Esaote
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Esaote Nuclear Medicine & Radio Pharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Main Business/Business Overview
7.8 Shimadzu
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Shimadzu Nuclear Medicine & Radio Pharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Main Business/Business Overview
7.9 TriFoil Imaging
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Main Business/Business Overview
7.10 Biosensors International Group, Ltd
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.10.4 Main Business/Business Overview

8 NUCLEAR MEDICINE & RADIO PHARMACEUTICALS MANUFACTURING COST ANALYSIS

8.1 Nuclear Medicine & Radio Pharmaceuticals Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Nuclear Medicine & Radio Pharmaceuticals

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Nuclear Medicine & Radio Pharmaceuticals Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Nuclear Medicine & Radio Pharmaceuticals Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL NUCLEAR MEDICINE & RADIO PHARMACEUTICALS MARKET FORECAST (2017-2022)

12.1 Global Nuclear Medicine & Radio Pharmaceuticals Capacity, Production, Revenue Forecast (2017-2022)
  12.1.1 Global Nuclear Medicine & Radio Pharmaceuticals Capacity, Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Nuclear Medicine & Radio Pharmaceuticals Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Nuclear Medicine & Radio Pharmaceuticals Price and Trend Forecast (2017-2022)
12.2 Global Nuclear Medicine & Radio Pharmaceuticals Production, Consumption, Import and Export Forecast by Region (2017-2022)
  12.2.1 North America Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Nuclear Medicine & Radio Pharmaceuticals Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Nuclear Medicine & Radio Pharmaceuticals Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Nuclear Medicine & Radio Pharmaceuticals
Figure Global Nuclear Medicine & Radio Pharmaceuticals Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
Table Major Manufacturers of Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
Figure Product Picture of Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
Table Major Manufacturers of Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
Figure Global Nuclear Medicine & Radio Pharmaceuticals Consumption (K Units) by Applications (2012-2022)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Consumption Market Share by Applications in 2016
Figure Diagnostic Applications: SPECT, PET. Examples
Table Key Downstream Customer in Diagnostic Applications: SPECT, PET.
Figure Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. Examples
Table Key Downstream Customer in Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.
Figure Global Nuclear Medicine & Radio Pharmaceuticals Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2012-2022)
Figure North America Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Capacity, Production (K Units) Status and Outlook (2012-2022)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Major Players Product Capacity (K Units) (2012-2017)
Table Global Nuclear Medicine & Radio Pharmaceuticals Capacity (K Units) of Key Manufacturers (2012-2017)
Table Global Nuclear Medicine & Radio Pharmaceuticals Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Capacity (K Units) of Key Manufacturers in 2016
Figure Global Nuclear Medicine & Radio Pharmaceuticals Capacity (K Units) of Key Manufacturers in 2017
Figure Global Nuclear Medicine & Radio Pharmaceuticals Major Players Product Production (K Units) (2012-2017)
Table Global Nuclear Medicine & Radio Pharmaceuticals Production (K Units) of Key Manufacturers (2012-2017)
Table Global Nuclear Medicine & Radio Pharmaceuticals Production Share by Manufacturers (2012-2017)
Figure 2016 Nuclear Medicine & Radio Pharmaceuticals Production Share by Manufacturers
Figure 2017 Nuclear Medicine & Radio Pharmaceuticals Production Share by Manufacturers
Figure Global Nuclear Medicine & Radio Pharmaceuticals Major Players Product Revenue (Million USD) (2012-2017)
Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Manufacturers
Table 2017 Global Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Manufacturers
Table Global Market Nuclear Medicine & Radio Pharmaceuticals Average Price (USD/Unit) of Key Manufacturers (2012-2017)
Figure Global Market Nuclear Medicine & Radio Pharmaceuticals Average Price (USD/Unit) of Key Manufacturers in 2016
Table Manufacturers Nuclear Medicine & Radio Pharmaceuticals Manufacturing Base Distribution and Sales Area
Table Manufacturers Nuclear Medicine & Radio Pharmaceuticals Product Category
Figure Nuclear Medicine & Radio Pharmaceuticals Market Share of Top 3 Manufacturers
Figure Nuclear Medicine & Radio Pharmaceuticals Market Share of Top 5 Manufacturers
Table Global Nuclear Medicine & Radio Pharmaceuticals Capacity (K Units) by Region (2012-2017)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Capacity Market Share by Region (2012-2017)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Capacity Market Share by Region (2012-2017)
Figure 2016 Global Nuclear Medicine & Radio Pharmaceuticals Capacity Market Share by Region
Table Global Nuclear Medicine & Radio Pharmaceuticals Production by Region (2012-2017)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Production (K Units) by Region (2012-2017)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Production Market Share by Region (2012-2017)
Figure 2016 Global Nuclear Medicine & Radio Pharmaceuticals Production Market Share by Region
Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) by Region (2012-2017)
Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Region (2012-2017)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Region (2012-2017)
Table 2016 Global Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Region
Figure Global Nuclear Medicine & Radio Pharmaceuticals Capacity, Production (K Units) and Growth Rate (2012-2017)
Table Global Nuclear Medicine & Radio Pharmaceuticals Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table North America Nuclear Medicine & Radio Pharmaceuticals Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Europe Nuclear Medicine & Radio Pharmaceuticals Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table China Nuclear Medicine & Radio Pharmaceuticals Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Japan Nuclear Medicine & Radio Pharmaceuticals Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table India Nuclear Medicine & Radio Pharmaceuticals Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Global Nuclear Medicine & Radio Pharmaceuticals Consumption (K Units) Market by Region (2012-2017)
Table Global Nuclear Medicine & Radio Pharmaceuticals Consumption Market Share by Region (2012-2017)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Consumption Market Share by Region (2012-2017)
Figure 2016 Global Nuclear Medicine & Radio Pharmaceuticals Consumption (K Units) Market Share by Region
Table North America Nuclear Medicine & Radio Pharmaceuticals Production, Consumption, Import & Export (K Units) (2012-2017)
Table Europe Nuclear Medicine & Radio Pharmaceuticals Production, Consumption, Import & Export (K Units) (2012-2017)
Table China Nuclear Medicine & Radio Pharmaceuticals Production, Consumption, Import & Export (K Units) (2012-2017)
Table Japan Nuclear Medicine & Radio Pharmaceuticals Production, Consumption, Import & Export (K Units) (2012-2017)
Table Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Production, Consumption, Import & Export (K Units) (2012-2017)
Table India Nuclear Medicine & Radio Pharmaceuticals Production, Consumption, Import & Export (K Units) (2012-2017)
Table Global Nuclear Medicine & Radio Pharmaceuticals Production (K Units) by Type (2012-2017)
Table Global Nuclear Medicine & Radio Pharmaceuticals Production Share by Type (2012-2017)
Figure Production Market Share of Nuclear Medicine & Radio Pharmaceuticals by Type (2012-2017)
Figure 2016 Production Market Share of Nuclear Medicine & Radio Pharmaceuticals by Type
Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) by Type (2012-2017)
Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Nuclear Medicine & Radio Pharmaceuticals by Type (2012-2017)
Figure 2016 Revenue Market Share of Nuclear Medicine & Radio Pharmaceuticals by Type
Table Global Nuclear Medicine & Radio Pharmaceuticals Price (USD/Unit) by Type (2012-2017)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Production Growth by Type (2012-2017)
Table Global Nuclear Medicine & Radio Pharmaceuticals Consumption (K Units) by Application (2012-2017)
Table Global Nuclear Medicine & Radio Pharmaceuticals Consumption Market Share by Application (2012-2017)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Consumption Market Share by Applications (2012-2017)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Consumption Market Share by Application in 2016
Table Global Nuclear Medicine & Radio Pharmaceuticals Consumption Growth Rate by Application (2012-2017)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Consumption Growth Rate by Application (2012-2017)
Table GE Healthcare Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate (2012-2017)
Figure GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Market Share (2012-2017)
Figure GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share (2012-2017)
Table Philips Healthcare Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate (2012-2017)
Figure Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Market Share (2012-2017)
Figure Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share (2012-2017)
Table Siemens Healthcare Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate (2012-2017)
Figure Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Market Share (2012-2017)
Figure Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share (2012-2017)
Table Toshiba Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Toshiba Nuclear Medicine & Radio Pharmaceuticals Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Toshiba Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate (2012-2017)
Figure Toshiba Nuclear Medicine & Radio Pharmaceuticals Production Market Share (2012-2017)
Figure Toshiba Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share (2012-2017)
Table Hitachi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hitachi Nuclear Medicine & Radio Pharmaceuticals Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hitachi Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate (2012-2017)
Figure Hitachi Nuclear Medicine & Radio Pharmaceuticals Production Market Share (2012-2017)
Figure Hitachi Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share (2012-2017)
Table Carestream Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Carestream Nuclear Medicine & Radio Pharmaceuticals Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Carestream Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate (2012-2017)
Figure Carestream Nuclear Medicine & Radio Pharmaceuticals Production Market Share (2012-2017)
Figure Carestream Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share (2012-2017)
Table Esaote Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Esaote Nuclear Medicine & Radio Pharmaceuticals Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Esaote Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate (2012-2017)
Figure Esaote Nuclear Medicine & Radio Pharmaceuticals Production Market Share (2012-2017)
Figure Esaote Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share (2012-2017)
Table Shimadzu Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shimadzu Nuclear Medicine & Radio Pharmaceuticals Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Shimadzu Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate (2012-2017)
Figure Shimadzu Nuclear Medicine & Radio Pharmaceuticals Production Market Share (2012-2017)
Figure Shimadzu Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share (2012-2017)
Table TriFoil Imaging Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate (2012-2017)
Figure TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Production Market Share (2012-2017)
Figure TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share (2012-2017)
Table Biosensors International Group, Ltd Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate (2012-2017)
Figure Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Production Market Share (2012-2017)
Figure Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nuclear Medicine & Radio Pharmaceuticals
Figure Manufacturing Process Analysis of Nuclear Medicine & Radio Pharmaceuticals
Figure Nuclear Medicine & Radio Pharmaceuticals Industrial Chain Analysis
Table Raw Materials Sources of Nuclear Medicine & Radio Pharmaceuticals Major Manufacturers in 2016
Table Major Buyers of Nuclear Medicine & Radio Pharmaceuticals
Table Distributors/Traders List
Figure Global Nuclear Medicine & Radio Pharmaceuticals Capacity, Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Price (Million USD) and Trend Forecast (2017-2022)
Table Global Nuclear Medicine & Radio Pharmaceuticals Production (K Units) Forecast by Region (2017-2022)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Production Market Share Forecast by Region (2017-2022)
Table Global Nuclear Medicine & Radio Pharmaceuticals Consumption (K Units) Forecast by Region (2017-2022)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Consumption Market Share Forecast by Region (2017-2022)
Figure North America Nuclear Medicine & Radio Pharmaceuticals Production (K Units) and Growth Rate Forecast (2017-2022)
Figure North America Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Nuclear Medicine & Radio Pharmaceuticals Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Nuclear Medicine & Radio Pharmaceuticals Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure China Nuclear Medicine & Radio Pharmaceuticals Production (K Units) and Growth Rate Forecast (2017-2022)
Figure China Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Nuclear Medicine & Radio Pharmaceuticals Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Japan Nuclear Medicine & Radio Pharmaceuticals Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Nuclear Medicine & Radio Pharmaceuticals Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure India Nuclear Medicine & Radio Pharmaceuticals Production (K Units) and Growth Rate Forecast (2017-2022)
Figure India Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Nuclear Medicine & Radio Pharmaceuticals Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Table Global Nuclear Medicine & Radio Pharmaceuticals Production (K Units) Forecast by Type (2017-2022)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Production (K Units) Forecast by Type (2017-2022)
Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share Forecast by Type (2017-2022)
Table Global Nuclear Medicine & Radio Pharmaceuticals Price Forecast by Type (2017-2022)
Table Global Nuclear Medicine & Radio Pharmaceuticals Consumption (K Units) Forecast by Application (2017-2022)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Consumption (K Units) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source